首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   51298篇
  免费   5444篇
  国内免费   676篇
耳鼻咽喉   464篇
儿科学   2194篇
妇产科学   1017篇
基础医学   6255篇
口腔科学   1499篇
临床医学   9083篇
内科学   4697篇
皮肤病学   311篇
神经病学   5539篇
特种医学   891篇
外国民族医学   4篇
外科学   3632篇
综合类   4917篇
现状与发展   6篇
一般理论   12篇
预防医学   9374篇
眼科学   594篇
药学   3769篇
  47篇
中国医学   1447篇
肿瘤学   1666篇
  2024年   475篇
  2023年   1133篇
  2022年   1457篇
  2021年   2215篇
  2020年   2421篇
  2019年   2403篇
  2018年   2141篇
  2017年   2186篇
  2016年   2053篇
  2015年   2092篇
  2014年   3061篇
  2013年   3983篇
  2012年   2747篇
  2011年   2892篇
  2010年   2588篇
  2009年   2504篇
  2008年   2406篇
  2007年   2389篇
  2006年   2046篇
  2005年   1808篇
  2004年   1529篇
  2003年   1327篇
  2002年   1098篇
  2001年   940篇
  2000年   828篇
  1999年   752篇
  1998年   696篇
  1997年   566篇
  1996年   514篇
  1995年   482篇
  1994年   425篇
  1993年   360篇
  1992年   326篇
  1991年   268篇
  1990年   265篇
  1989年   197篇
  1988年   193篇
  1987年   170篇
  1986年   187篇
  1985年   221篇
  1984年   209篇
  1983年   124篇
  1982年   112篇
  1981年   136篇
  1980年   126篇
  1979年   78篇
  1978年   76篇
  1977年   40篇
  1976年   47篇
  1974年   21篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
目的促进医院药房药师针对特殊人群的用药咨询工作质量。方法选择医院门诊289例特殊人员(孕妇、老人、未成年人监护人)用药咨询记录进行调查。结果与结论做好药房门诊的特殊患者用药咨询工作,可帮助患者提高合理、正确用药知识,从正确用药、减少误服和超量用药、不规范用药等方面起到辅助医疗作用。  相似文献   
992.
目的了解感染铜绿假单胞菌老年患者的耐药性特征,为临床预防及治疗提供理论依据。方法收集我院2013年1月至2014年7月感染铜绿假单胞菌的老年患者病例233例,采用Kirby-Bauer纸片扩散法和CLSI 2013年版判断标准进行耐药性监测,并用SPSS 19.0统计软件进行数据分析。结果阿米卡星耐药率最低,其他耐药率低于60%的包括庆大霉素、妥布霉素、复方新诺明、罗米沙星、左氧氟沙星、环丙沙星、美罗培南、亚胺培南、头孢吡肟、哌拉西林、哌拉西林/他唑巴坦、头孢他啶。结论老年患者中分离的铜绿假单胞菌呈现出多重耐药且耐药率不断上升的特点,建议根据药敏结果选择抗菌药物并联合用药。  相似文献   
993.
In 2005, the European Respiratory Society (ERS) launched a project to harmonise education and training and to address the heterogeneity of respiratory health training across Europe. Since then, various educational activities have been developed for different target audiences. This article will describe the overall methodology and the projects developed over the years, detailing their objectives and target audiences. Moving forward, ERS strives to provide a structure for the continuing professional development of respiratory physicians.  相似文献   
994.
995.
Background and aimsThis study aimed to assess the effects of vildagliptin on the prevention of cardiovascular diseases in Thai patients with type 2 diabetes mellitus using the Thai Cardiovascular Risk Score.MethodsAll patients with type 2 diabetes mellitus who used vildagliptin at a secondary hospital in Thailand were screened and recruited. The relevant variables were obtained from patient medication charts at the first visit on which the patients were prescribed vildagliptin and from the 6-month, 12-month, and 18-month post-treatment visits. The Thai Cardiovascular Risk Score was calculated and monitored as a primary outcome, whereas changes in separate cardiometabolic parameters were assessed as secondary outcomes.ResultsOf the 321 patients screened, only 95 were recruited for the analysis. The average 10-year cardiovascular risks of patients increased from 19.65% at baseline to 20.74%, 20.69%, and 23.78% at 6, 12, and 18 months post treatment, respectively. However, a better trend of reduction in cardiovascular risk was observed in patients with a high baseline cardiovascular risk. The glucose-lowering effects of vildagliptin were significantly observed 12 months of treatment onwards, but non-significant changes were found in lipid and blood pressure levels as well as body mass index.ConclusionVildagliptin provided a promising glucose-lowering effect in Thai patients with type 2 diabetes mellitus. However, the mean 10-year cardiovascular risk did not significantly decrease. However, a negative correlation between cardiovascular risk reduction and baseline cardiovascular risk was observed in this study. Low sample size was a major limitation of this study.  相似文献   
996.
997.
998.
999.
1000.
BackgroundPrecision health calls for collecting and analyzing large amounts of data to capture an individual's unique behavior, lifestyle, genetics, and environmental context. The diffusion of digital tools has led to a significant growth of patient generated health data (PGHD), defined as health-related data created, gathered or inferred by or from patients and for which the patient controls data collection and data sharing.PurposeWe assessed the current evidence of the impact of PGHD use in clinical practice and provide recommendations for the formal integration of PGHD in clinical care.MethodsWe searched PubMed, Ovid, Embase, CINAHL, Web of Science, and Scopus up to May 2018. Inclusion criteria were applied and four reviewers screened titles and abstracts and consequently full articles.FindingsOur systematic literature review identified 21 studies that examined the use of PGHD in clinical settings. Integration of PGHD into electronic records was extremely limited, and decision support capabilities were for the most part basic.DiscussionPGHD and other types of patient-reported data will be part of the health care system narrative and we must continue efforts to understand its impact on health outcomes, costs, and patient satisfaction. Nursing scientists need to lead the process of defining the role of PGHD in the era of precision health.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号